| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings, Inc. | John Johnson | Director | Aug 13, 2025 | Sale | $7.32 | 107,500 | 786,459 | 833,483 | Aug 15, 2025, 04:57 PM | |
| AXGN | Axogen, Inc. | John Johnson | Director | Jun 09, 2025 | Sale | $10.61 | 4,073 | 43,215 | 24,943 | Jun 11, 2025, 04:23 PM | |
| AXGN | Axogen, Inc. | John Johnson | Director | Sep 01, 2024 | Option/RSU Exercise | - | 11,904 | - | 29,016 | Sep 04, 2024, 09:13 PM | |
| XERS | Xeris Biopharma Holdings, Inc. | John Johnson | Director | Mar 18, 2024 | Option/RSU Exercise | $1.99 | 215,600 | 429,044 | 751,412 | Mar 18, 2024, 05:32 PM | |
| AXGN | Axogen, Inc. | John Johnson | Director | Jun 01, 2023 | Option/RSU Exercise | - | 6,459 | - | 6,459 | Jun 05, 2023, 06:53 PM |